Company Valuation: American Oncology Network, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024
Market Cap 1 - - 56.35 137.1
Change - - - 143.33%
Enterprise Value (EV) - - 125.3 215.2
Change - - - 71.77%
P/E - - -4.32x -5.7x
PBR - - -0.35x -3.31x
PEG - - - 0.2x
Capitalization / Revenue - - 0.04x 0.08x
EV / Revenue - - 0x 0x
EV / EBITDA - - -0x -0x
EV / EBIT - - -0x -0x
EV / FCF - - - -
FCF Yield - - - -
Dividend per Share 2 - - - -
Rate of return - - - -
EPS 2 - - -1.365 -0.8874
Distribution rate - - - -
Net sales 1 943.7 1,150 1,279 1,759
EBITDA 1 6.99 12.28 -4.668 -5.575
EBIT 1 0.911 5.566 -13.12 -16.09
Net income 1 -0.105 2.589 -5.542 -3.973
Net Debt 36.34 91.97 68.94 78.1
Reference price 2 9.75 10.04 5.90 5.06
Nbr of stocks (in thousands) - - 9,550 27,096
Announcement Date 1/6/23 4/28/23 3/28/24 3/27/25
1USD in Million2USD
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 371M
13.35x0.41x8.48x2.9% 115B
14.54x1.82x9.1x0.72% 92.89B
14.08x1.53x9.22x2.53% 29.82B
24.32x2.69x13.64x1.34% 27.31B
31.77x5.73x23.88x2.2% 21.24B
8.07x1.44x6.55x-.--% 21.09B
17.13x1.57x7.9x4.61% 15.7B
13.3x1.64x7.94x0.86% 11.68B
13.79x1x5.61x3.57% 11.87B
Average 16.71x 1.98x 10.26x 2.08% 34.74B
Weighted average by Cap. 15.58x 1.56x 9.80x 1.97%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. AONC Stock
  4. Valuation American Oncology Network, Inc.
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!